ATAI Life Sciences N.V. Common Shares
ATAI •
Buy Open
Signal type
Buy
Status
Open
Open Price
$3.99
Stop Loss
$3.62
Performance
-3.51%
Days Open
1
Signal Setup
Signal Type Buy
Status Open
Open Date Apr 14, 2026
Open Price $3.99
Stop Loss $3.62
Timespan Day
Company Profile
Name ATAI Life Sciences N.V. Common Shares
Ticker ATAI
Market Cap $464.59M
Sector PHARMACEUTICAL PREPARATIONS
Latest Close $3.85
List Date Jun 18, 2021
Description
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.
Website Open Company Website